Comprehensive cataloging of miR-363 as a therapeutic & non-invasive biomarker of prostate cancer.

Diagnostic potential of miR-363 According to ROC curve analysis, miR-363 covered a highly significant ( P <0.0001) area in both PCa tissue (0.969; sensitivity: 85%; specificity 100%) as well as serum (0.988; sensitivity: 97.5%; specificity: 87.5%) ( Fig. 3A & B).

also in 132,142 other papers